A retrospective study of 932 second trimester terminations using gemeprost (16, 16 dimethyl-trans Δ2 PGE1 methyl ester)
- 1 July 1992
- journal article
- Published by Elsevier in Prostaglandins
- Vol. 44 (1), 65-74
- https://doi.org/10.1016/0090-6980(92)90108-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Uterine rupture in midtrimester abortion. A complication of gemeprost vaginal pessaries and oxytocin. Case reportBJOG: An International Journal of Obstetrics and Gynaecology, 1991
- 2308 second trimester terminations using extra-amniotic or intra-amniotic prostaglandin E2: an analysis of efficacy and complicationsBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Prostaglandin-induced pregnancy termination: Further studies using gemeprost (16, 16 dimethyl-trans-Δ2-PGE1 methyl ester vaginal pessaries in the early second trimesterProstaglandins, 1987
- Midtrimester abortion by dilatation and evacuation versus intra-amniotic instillation of prostaglandin F2α: A randomized clinical trialAmerican Journal of Obstetrics and Gynecology, 1980
- Complications from Legally-Induced AbortionObstetrical & Gynecological Survey, 1979
- Mid-Trimester Abortion by Dilatation and EvacuationNew England Journal of Medicine, 1977
- Joint Program for the Study of Abortion (JPSA): Early Medical Complications of Legal AbortionStudies in Family Planning, 1972
- Use of Prostaglandin E2 for Therapeutic AbortionBMJ, 1970
- Induction of Abortion by Prostaglandins E1 and E2BMJ, 1970
- THERAPEUTIC ABORTION USING PROSTAGLANDIN F2αThe Lancet, 1970